MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03552nam a22003857a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
210628s20212021 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
1522-1946 |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1002/ccd.29749 [doi] |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| PMID |
34004077 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation. |
| 251 ## - Source |
|---|
| Source |
Catheterization & Cardiovascular Interventions. 2021 May 18 |
| 252 ## - Abbreviated Source |
|---|
| Abbreviated source |
Catheter Cardiovasc Interv. 2021 May 18 |
| 253 ## - Journal Name |
|---|
| Journal name |
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Year |
2021 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Manufacturer |
FY2021 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Publication date |
2021 May 18 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
aheadofprint |
| 266 ## - Date added to catalog |
|---|
| Date added to catalog |
2021-06-28 |
| 501 ## - WITH NOTE |
|---|
| Local holdings |
Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006 |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
BACKGROUND: The currently enrolling CLASP IID/IIF pivotal trial is a multicenter, prospective, randomized trial assessing the safety and effectiveness of the PASCAL transcatheter valve repair system in patients with clinically significant MR. The trial allows for up to three roll-in patients per site. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
CONCLUSIONS: Early results representing sites with first experience with the PASCAL repair system showed favorable 30-day outcomes in patients with DMR>=3+ at prohibitive surgical risk. Copyright (c) 2021 Wiley Periodicals LLC. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
METHODS: Eligibility criteria were: DMR >=3+, prohibitive surgical risk, and deemed suitable for transcatheter repair by the local heart team. Trial oversight included a central screening committee and echocardiographic core laboratory. The primary safety endpoint was a 30-day composite MAE: cardiovascular mortality, stroke, myocardial infarction (MI), new need for renal replacement therapy, severe bleeding, and non-elective mitral valve re-intervention, adjudicated by an independent clinical events committee. Thirty-day echocardiographic, functional, and quality of life outcomes were assessed. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
OBJECTIVES: We report the 30-day outcomes from the roll-in cohort of the CLASP IID trial, representing the first procedures performed by each site. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
RESULTS: A total of 45 roll-in patients with mean age of 83 years and 69% in NYHA class III/IV were treated. Successful implantation was achieved in 100%. The 30-day composite MAE rate was 8.9% including one cardiovascular death (2.2%) due to severe bleeding from a hemorrhagic stroke, one MI, and no need for re-intervention. MR<=1+ was achieved in 73% and <=2+ in 98% of patients. 89% of patients were in NYHA class I/II (p < .001) with improvements in 6MWD (30 m; p = .054) and KCCQ (17 points; p < .001). |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Institution |
MedStar Heart & Vascular Institute |
| 657 ## - INDEX TERM--FUNCTION |
|---|
| Medline publication type |
Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Satler, Lowell F |
| 790 ## - Authors |
|---|
| All authors |
Chhatriwalla A, CLASP IID Pivotal Trial Investigators, Davidson C, Dhoble A, Gillam L, Gray W, Greenbaum A, Guerrero M, Hermiller J, Herrmann HC, Ibrahim H, Kapadia S, Kliger C, Kodali S, Koulogiannis K, Laham R, Lazkani M, Lee D, Lim DS, Mahoney P, Marcoff L, Petrossian G, Rassi A, Rodes-Cabau J, Sarembock IJ, Satler L, Shah P, Smith RL, Vora A, Zahr F |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| DOI |
<a href="https://dx.doi.org/10.1002/ccd.29749">https://dx.doi.org/10.1002/ccd.29749</a> |
| Public note |
https://dx.doi.org/10.1002/ccd.29749 |
| 858 ## - ORCID |
|---|
| ORCID text |
Satler, Lowell |
| Orcid |
<a href="https://orcid.org/0000-0001-6446-2683">https://orcid.org/0000-0001-6446-2683</a> |
| Name |
https://orcid.org/0000-0001-6446-2683 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Journal Article |
| Item type description |
Article |
